Fundz

Experic Raises Additional Capital In Series B Extension To Support Additional Analytical Laboratory And Spray Drying Investments

PRIVATEOct 05, 2023

Round Type

Series B

Cranbury TownshipManufacturingBiotechnologyHealth Carepharmaceuticals

Description

Experic, a contract development and manufacturing organization (CDMO) and clinical supply services company serving the biopharmaceutical industry, announced today the successful completion of a Series B extension round of financing. The additional capital is earmarked to support the company's double-digit organic growth and strategic investments in key operational assets.

Who to call at Experic, and when

A new round usually means Experic is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Experic raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Experic, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Experic. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Experic

Location

2 Clarke Dr

Cranbury Township, New Jersey, United States

About

Experic is a contract development and manufacturing organization (CDMO) and clinical trial supply services company dedicated to revolutionizing pharmaceutical development, manufacturing, and clinical trial supply. Established in 2018, Experic offers a comprehensive suite of services, including process development, analytical and formulation development, clinical and commercial manufacturing, and clinical packaging and logistics. Specializing in challenging powders and inhalation products, our expertise encompasses capsules, and low-dose dry powder inhalation therapies. Operating from our state-of-the-art, Class A cGMP facility in Cranbury, New Jersey, as well as our Clinical Supply Center facility in Kilbeggan, Ireland, we manage the global delivery of high-quality products, even for expedited projects. Our team of industry leaders brings decades of experience in pharmaceutical product development and clinical trial supplies, ensuring strategic vision and execution for every project.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Experic raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contactsDave W., CHAIRMAN & CEO hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Experic's next move

See what Strategic adds

Funding Insights

What this usually means
Timeline to next round
Series B companies typically work for 15-20 months before raising new capital
Growth expectations
Series B companies are expected to scale rapidly and expand market reach

Experic raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.